{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:37:44Z","timestamp":1793306264792,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02284-0","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:20:56Z","timestamp":1776698456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Machine learning prediction of metabolic dysregulation in women with polycystic ovary syndrome: development and validation of hemato-inflammatory predictive models"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7614-2440","authenticated-orcid":false,"given":"Meryem Kececi","family":"Oguzhanoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3251-1919","authenticated-orcid":false,"given":"Kursat","family":"Oguzhanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0987-740X","authenticated-orcid":false,"given":"Senem Karacabey","family":"Cakmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6190-3727","authenticated-orcid":false,"given":"Busra Seker","family":"Atas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5767-7894","authenticated-orcid":false,"given":"Ali","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"4","key":"2284_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman M, Boyle LA, Norman J, Mousa RJ, Joham A, A. E., International PCOS Network. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertil Steril. 2023;120(4):767\u201393.","journal-title":"Fertil Steril"},{"issue":"11","key":"2284_CR2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, Androgen Excess and PCOS Society (AES). American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome\u2013Part 1. Endocr Pract. 2015;21(11):1291\u2013300.","journal-title":"Endocr Pract"},{"issue":"1","key":"2284_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6\u201316.","journal-title":"Fertil Steril"},{"issue":"4","key":"2284_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cen.14421","volume":"95","author":"TM Barber","year":"2021","unstructured":"Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol. 2021;95(4):531\u201341.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"2284_CR5","first-page":"1412","volume":"116","author":"NS Kakoly","year":"2021","unstructured":"Kakoly NS, Khomami MB, Joham AE, et al. Health and metabolic outcomes in lean versus obese polycystic ovary syndrome: a systematic literature review and meta-analysis. Fertil Steril. 2021;116(6):1412\u201325.","journal-title":"Fertil Steril"},{"issue":"12","key":"2284_CR6","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, et al. Clinical practice guideline for the diagnosis and treatment of polycystic ovary syndrome by the Endocrine Society. J Clin Endocrinol Metab. 2013;98(12):4565\u201392.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2284_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT. Polycystic ovary syndrome. Nat Reviews Disease Primers. 2024;10(1):27.","journal-title":"Nat Reviews Disease Primers"},{"issue":"4","key":"2284_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/humupd\/dmq001","volume":"16","author":"LJ Moran","year":"2010","unstructured":"Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes, and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347\u201363.","journal-title":"Hum Reprod Update"},{"key":"2284_CR9","doi-asserted-by":"crossref","unstructured":"Imtiaz F, Shafique K, Mirza SS, et al. The neutrophil-lymphocyte ratio as an indicator of systemic inflammation in common chronic diseases within the Asian population. Int Arch Med. 2012;5(1):2.","DOI":"10.1186\/1755-7682-5-2"},{"issue":"1","key":"2284_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13104-016-2335-5","volume":"10","author":"P Forget","year":"2017","unstructured":"Forget P, Khalifa C, Defour JP, et al. What is the standard value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10(1):12.","journal-title":"BMC Res Notes"},{"key":"2284_CR11","doi-asserted-by":"crossref","unstructured":"Li L, Yu J, Zhou Z. Association between neutrophil-to-lymphocyte ratio and polycystic ovary syndrome: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2022;101(38):e30579.","DOI":"10.1097\/MD.0000000000030579"},{"issue":"1","key":"2284_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12902-024-01564-x","volume":"24","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu H. Correlation between insulin resistance and the rate of neutrophils-lymphocytes, monocytes-lymphocytes, platelets-lymphocytes in type 2 diabetic patients. BMC Endocr Disorders. 2024;24(1):42.","journal-title":"BMC Endocr Disorders"},{"issue":"11","key":"2284_CR13","first-page":"2570","volume":"24","author":"X Liu","year":"2015","unstructured":"Liu X, Zhang Q, Ding Y, et al. The neutrophil-to-lymphocyte ratio predicts C-reactive protein levels in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2015;24(11):2570\u20136.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"2284_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12933-023-01998-y","volume":"22","author":"G Dong","year":"2023","unstructured":"Dong G, Gan M, Xu S, Xie Y, Zhou M, Wu L. The neutrophil-lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: Evidence from the NHANES 2003\u20132016. Cardiovasc Diabetol. 2023;22(1):267.","journal-title":"Cardiovasc Diabetol"},{"issue":"14","key":"2284_CR15","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMra1814259","volume":"380","author":"A Rajkomar","year":"2019","unstructured":"Rajkomar A, Dean J, Kohane I. Machine Learning in Medicine. N Engl J Med. 2019;380(14):1347\u201358.","journal-title":"N Engl J Med"},{"key":"2284_CR16","doi-asserted-by":"publisher","first-page":"1106625","DOI":"10.3389\/fendo.2023.1106625","volume":"14","author":"FJ Barrera","year":"2023","unstructured":"Barrera FJ, Brown EDL, Rojo A, Obeso J, Plata H, Lincango EP, Terry N, Rodriguez-Gutierrez R, Hall JE, Shekhar S. Application of machine learning and artificial intelligence in the diagnosis and classification of polycystic ovarian syndrome: A systematic review. Front Endocrinol. 2023;14:1106625.","journal-title":"Front Endocrinol"},{"issue":"1","key":"2284_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol EJ. High-performance medicine: the integration of human and artificial intelligence. Nat Med. 2019;25(1):44\u201356.","journal-title":"Nat Med"},{"issue":"2","key":"2284_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/obr.12762","volume":"20","author":"SS Lim","year":"2019","unstructured":"Lim SS, Kakoly NS, Tan JWJ, Fitzgerald G, Bahri Khomami M, Joham AE, Cooray SD, Misso ML, Norman RJ, Harrison CL, Ranasinha S, Teede HJ, Moran LJ. Metabolic syndrome in polycystic ovary syndrome: A systematic review, meta-analysis and meta-regression. Obes Rev. 2019;20(2):339\u201352.","journal-title":"Obes Rev"},{"issue":"9","key":"2284_CR19","first-page":"668","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, Boyle J, Teede HJ. Polycystic ovary syndrome. The lancet. Diabetes Endocrinol. 2022;10(9):668\u201380.","journal-title":"Diabetes Endocrinol"},{"key":"2284_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jmsacl.2023.01.006","volume":"28","author":"D French","year":"2023","unstructured":"French D. Clinical utility of laboratory developed mass spectrometry assays for steroid hormone testing. J Mass Spectrom Adv Clin Lab. 2023;28:13\u20139.","journal-title":"J Mass Spectrom Adv Clin Lab"},{"issue":"1","key":"2284_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0587.2012.07348.x","volume":"36","author":"CF Dormann","year":"2013","unstructured":"Dormann CF, Elith J, Bacher S, et al. Collinearity: an examination of methodologies for addressing it and a novel approach. Ecography. 2013;36(1):27\u201346.","journal-title":"Ecography"},{"key":"2284_CR22","volume-title":"Essentials of Applied Pathophysiology","author":"I Peate","year":"2016","unstructured":"Peate I, Nair M. Essentials of Applied Pathophysiology. Oxford: Wiley-Blackwell; 2016."},{"key":"2284_CR23","doi-asserted-by":"crossref","unstructured":"Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference, and prediction. Second edition. Springer, New York; 2009.","DOI":"10.1007\/978-0-387-84858-7"},{"issue":"4","key":"2284_CR24","first-page":"1","volume":"6","author":"S Kaufman","year":"2011","unstructured":"Kaufman S, Rosset S, Perlich C. Leakage in data mining: formulation, detection, and prevention. ACM Trans Knowl Discovery Data. 2011;6(4):1\u201321.","journal-title":"ACM Trans Knowl Discovery Data"},{"key":"2284_CR25","doi-asserted-by":"crossref","unstructured":"Wilimitis D, Walsh CG. Practical considerations and applied examples of cross-validation for model development and evaluation in health care: tutorial. JMIR AI. 2023;2:e49023.","DOI":"10.2196\/49023"},{"issue":"5","key":"2284_CR26","first-page":"1016","volume":"49","author":"A Khammar","year":"2020","unstructured":"Khammar A, Yarahmadi M, Madadizadeh F. What is analysis of covariance (ANCOVA) and how to correctly report its results in medical research? Iran J Public Health. 2020;49(5):1016\u20137.","journal-title":"Iran J Public Health"},{"issue":"546","key":"2284_CR27","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1080\/01621459.2023.2197686","volume":"119","author":"S Bates","year":"2024","unstructured":"Bates S, Hastie T, Tibshirani R. Cross-validation: What does it estimate and how well does it do it? J Am Stat Assoc. 2024;119(546):1434\u201345.","journal-title":"J Am Stat Assoc"},{"key":"2284_CR28","doi-asserted-by":"crossref","unstructured":"Adane T, Melku M, Worku YB, Fasil A, Aynalem M, Kelem A, Getawa S. The association between neutrophil-to-lymphocyte ratio and glycemic control in type 2 diabetes mellitus: a systematic review and meta-analysis. J Diabetes Res. 2023;2023:3117396.","DOI":"10.1155\/2023\/3117396"},{"issue":"1","key":"2284_CR29","first-page":"40","volume":"14","author":"NP Agarwal","year":"2021","unstructured":"Agarwal NP, Mazumdar K, Mazumdar R. Increased systemic and localized inflammation in polycystic ovary syndrome. J Hum Reproductive Sci. 2021;14(1):40.","journal-title":"J Hum Reproductive Sci"},{"issue":"1","key":"2284_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000515117","volume":"14","author":"Z Michailidou","year":"2022","unstructured":"Michailidou Z, Gomez-Salazar M, Alexaki VI. Innate immune cells in the adipose tissue in health and metabolic disease. J Innate Immun. 2022;14(1):4\u201330.","journal-title":"J Innate Immun"},{"key":"2284_CR31","volume-title":"Endotext","author":"I Kyrou","year":"2023","unstructured":"Kyrou I, Randeva HS, Tsigos C. Clinical issues associated with obesity. In: De Groot LJ, Chrousos G, Dungan K, et al. editors. Endotext. South Dartmouth: MDText.com, Inc.; 2023."},{"issue":"39","key":"2284_CR32","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","volume":"43","author":"F Kronenberg","year":"2022","unstructured":"Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky M, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, von Eckardstein A, Watts GF, Stock JK, Catapano AL. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: A European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925\u201346.","journal-title":"Eur Heart J"},{"key":"2284_CR33","doi-asserted-by":"publisher","first-page":"e074819","DOI":"10.1136\/bmj-2023-074819","volume":"384","author":"RD Riley","year":"2024","unstructured":"Riley RD, Archer L, Snell KIE, Ensor J, Dhiman P, Martin GP, Bonnett LJ, Collins GS. Evaluation of clinical prediction models (part 1): From development to external validation. BMJ. 2024;384:e074819.","journal-title":"BMJ"},{"issue":"1","key":"2284_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41512-024-00177-1","volume":"8","author":"L Barre\u00f1ada","year":"2024","unstructured":"Barre\u00f1ada L, Dhiman P, Timmerman D, Boulesteix A-L, Van Calster B. Understanding overfitting in random forest for probability estimation: A visualization and simulation study. Diagn Prognostic Res. 2024;8(1):14.","journal-title":"Diagn Prognostic Res"},{"key":"2284_CR35","doi-asserted-by":"publisher","first-page":"927312","DOI":"10.3389\/fbinf.2022.927312","volume":"2","author":"N Pudjihartono","year":"2022","unstructured":"Pudjihartono N, Fadason T, Kempa-Liehr AW, O\u2019Sullivan JM. A review of feature selection methods for machine learning-based disease risk prediction. Front Bioinf. 2022;2:927312.","journal-title":"Front Bioinf"},{"key":"2284_CR36","doi-asserted-by":"publisher","first-page":"1237729","DOI":"10.3389\/fimmu.2023.1237729","volume":"14","author":"SA Rizo-T\u00e9llez","year":"2023","unstructured":"Rizo-T\u00e9llez SA, Sekheri M, Filep JG. C-reactive protein: A target for therapy to reduce inflammation. Front Immunol. 2023;14:1237729.","journal-title":"Front Immunol"},{"issue":"2","key":"2284_CR37","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. Metabolic syndrome: Updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23(2):786.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2284_CR38","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: A new immune\u2013metabolic viewpoint for age-related diseases. Nat Reviews Endocrinol. 2018;14(10):576\u201390.","journal-title":"Nat Reviews Endocrinol"},{"issue":"6","key":"2284_CR39","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, Vera-Badillo FE, Aneja P, Oca\u00f1a A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, Tannock IF, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2284_CR40","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.fertnstert.2023.01.031","volume":"119","author":"K VanHise","year":"2023","unstructured":"VanHise K, Wang ET, Norris K, Azziz R, Pisarska MD, Chan JL. Racial and ethnic disparities in polycystic ovary syndrome. Fertil Steril. 2023;119(3):348\u201354.","journal-title":"Fertil Steril"},{"issue":"1","key":"2284_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12905-025-03553-1","volume":"25","author":"MB Ghalehzan","year":"2025","unstructured":"Ghalehzan MB, Afrasiabi A, Daneshmand F, Ali-Hassanzadeh M, Gharesi-Fard B, Majidi Z. Polymorphism of the Insulin Resistin (RETN) gene in susceptibility to Polycystic Ovary Syndrome (PCOS) in an Iranian population. BMC Womens Health. 2025;25(1):63.","journal-title":"BMC Womens Health"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02284-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02284-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02284-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T03:22:22Z","timestamp":1778210542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02284-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2284"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02284-0","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Institutional Ethics Committee of Haseki Training and Research Hospital (Protocol No: 169\u20132025) and was conducted in compliance with the Declaration of Helsinki. All participants furnished written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent"}},{"value":"All participants included in this research provided written informed consent prior to enrollment. Participants were comprehensively informed about the study objectives, methods, potential risks, and benefits. All participants voluntarily agreed to participate and were informed that they could withdraw from the study at any time without penalty or loss of benefits. No coercion or undue influence was applied to any participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}